DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Brefonalol
Brefonalol
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
Customs Tariff - Schedule
)&F1y3x PHARMACEUTICAL APPENDIX to THE
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Multimedia Appendix 1. Search Strategy Developed for Medline Via Ovid to Identify Existing Systematics Review. Concept 1: BP
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Stembook 2018.Pdf
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
The Pharmacological Treatment of Arterial Hypertension in Frail, Older Patients a Systematic Review
Pharmaceutical Appendix to the Tariff Schedule 2
Top View
Customs Tariff - Schedule Xxi - 1
(12) Patent Application Publication (10) Pub. No.: US 2005/0002865 A1 Klaveness Et Al
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pharmaceuticals Appendix
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Identification and Characterization of Antidiabetic And